WithdrawnNot Applicable

Comparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease

Stopped: Unable to recruit any subjects for this study

United States0Started 2006-03

Plain-language summary

This is an open-label cross-over randomized control study comparing the effect of modafinil and methylphenidate in patients with Parkinson's disease with excessive daytime sleepiness.

Who can participate

Age range50 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Veteran at study site Exclusion Criteria: * Patients unable to give consent * Diagnosis of EDS prior to diagnosis of PD * Brain injury due to trauma, CVA, tumor or anoxia

What they're measuring

Compare efficacy of the two agents in treating excessive daytime sleepiness at 4 and 8 weeks

Trial details

NCT IDNCT00393562

SponsorUS Department of Veterans Affairs

Sponsor typeFED

Study typeINTERVENTIONAL

Primary completion2007-10

View on ClinicalTrials.gov More Parkinson's Disease trials